Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1982-10-27
1984-09-11
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Lymphokine
424322, A61K 3117, A61K 3179
Patent
active
044709650
ABSTRACT:
An ophthalmic preparation for the treatment of glaucoma by the application to the glaucomatous eye of a celiprolol salt in a pharmaceutically acceptable ophthalmic carrier.
REFERENCES:
patent: 3930016 (1975-12-01), Berntsson et al.
patent: 4034009 (1977-07-01), Z/o/ lss et al.
patent: 4038313 (1977-07-01), Wilhelm
patent: 4120978 (1978-10-01), Wilhelm
patent: 4178374 (1979-12-01), Sweet
"Glaucoma Update"-Krieglstein et al.-editors-Springer-Verlag-New York-pp. 19-23 (1979)-Langham.
Chem. Abst. 71, 775(w) (1972)-Peori-Giraldi et al.
Arch. Ophthalmol. 95: 601-604 (1977)-Zimmerman et al.
Ophthalmalogica, Basel 184: 198-203 (1982)-Strempel.
Weiner Blinisch Wochenschrift, 90: 350-354 (1978)-Bonelli et al.
Pittner et al.: Celiprolol A Cardioselective Beta-Receptor Blocking Agent, (UL/2006/111, Chemie Linz AG Drug Division, 1982).
Kesselman Morris A.
Wolf Peter
Robinson Douglas W.
USV Pharmaceutical Corporation
LandOfFree
Celiprolol for the treatment of glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Celiprolol for the treatment of glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Celiprolol for the treatment of glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1194365